Skip to content
10-Q

Quarterly Report

GW PHARMACEUTICALS PLC

0001564590-21-022624

← back to feed
Filed
May 3, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 23, 2021 378.54M sh
Shares Diluted Q1 2021 · Mar 31, 2021 378.57M sh
Shares Diluted Q1 2021 · Mar 31, 2020 373.83M sh
Capex Q1 2021 · Mar 31, 2021 $7.94M
Capex Q1 2021 · Mar 31, 2020 $6.36M
Operating Cash Flow Q1 2021 · Mar 31, 2021 −$11.72M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$18.6M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $458.1M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $486.75M
Stockholders Equity Q1 2021 · Mar 31, 2021 $736.37M
Stockholders Equity Q1 2021 · Dec 31, 2020 $741.09M
Stockholders Equity Q1 2021 · Mar 31, 2020 $715.01M
Stockholders Equity Q1 2021 · Dec 31, 2019 $726.03M
Current Liabilities Q1 2021 · Mar 31, 2021 $160.25M
Current Liabilities Q1 2021 · Dec 31, 2020 $159.81M
Total Liabilities Q1 2021 · Mar 31, 2021 $197.97M
Total Liabilities Q1 2021 · Dec 31, 2020 $198.42M
Current Assets Q1 2021 · Mar 31, 2021 $718.73M
Current Assets Q1 2021 · Dec 31, 2020 $729.53M
Total Assets Q1 2021 · Mar 31, 2021 $934.34M
Total Assets Q1 2021 · Dec 31, 2020 $939.51M
Eps Diluted Q1 2021 · Mar 31, 2021 −$0.05
Eps Diluted Q1 2021 · Mar 31, 2020 −$0.02
Eps Basic Q1 2021 · Mar 31, 2021 −$0.05
Eps Basic Q1 2021 · Mar 31, 2020 −$0.02
Sga Expense Q1 2021 · Mar 31, 2021 $101.05M
Sga Expense Q1 2021 · Mar 31, 2020 $71.18M
Rd Expense Q1 2021 · Mar 31, 2021 $60.63M
Rd Expense Q1 2021 · Mar 31, 2020 $45.87M
Net Income Q1 2021 · Mar 31, 2021 −$19.68M
Net Income Q1 2021 · Mar 31, 2020 −$7.97M
Operating Income Q1 2021 · Mar 31, 2021 −$21.03M
Operating Income Q1 2021 · Mar 31, 2020 −$7.19M
Cost Of Revenue Q1 2021 · Mar 31, 2021 $11.81M
Cost Of Revenue Q1 2021 · Mar 31, 2020 $10.77M
Revenue Q1 2021 · Mar 31, 2021 $152.47M
Revenue Q1 2021 · Mar 31, 2020 $120.63M